36309735|t|Synaptic proteomics reveal distinct molecular signatures of cognitive change and C9ORF72 repeat expansion in the human ALS cortex.
36309735|a|Increasing evidence suggests synaptic dysfunction is a central and possibly triggering factor in Amyotrophic Lateral Sclerosis (ALS). Despite this, we still know very little about the molecular profile of an ALS synapse. To address this gap, we designed a synaptic proteomics experiment to perform an unbiased assessment of the synaptic proteome in the ALS brain. We isolated synaptoneurosomes from fresh-frozen post-mortem human cortex (11 controls and 18 ALS) and stratified the ALS group based on cognitive profile (Edinburgh Cognitive and Behavioural ALS Screen (ECAS score)) and presence of a C9ORF72 hexanucleotide repeat expansion (C9ORF72-RE). This allowed us to assess regional differences and the impact of phenotype and genotype on the synaptic proteome, using Tandem Mass Tagging-based proteomics. We identified over 6000 proteins in our synaptoneurosomes and using robust bioinformatics analysis we validated the strong enrichment of synapses. We found more than 30 ALS-associated proteins in synaptoneurosomes, including TDP-43, FUS, SOD1 and C9ORF72. We identified almost 500 proteins with altered expression levels in ALS, with region-specific changes highlighting proteins and pathways with intriguing links to neurophysiology and pathology. Stratifying the ALS cohort by cognitive status revealed almost 150 specific alterations in cognitively impaired ALS synaptic preparations. Stratifying by C9ORF72-RE status revealed 330 protein alterations in the C9ORF72-RE +ve group, with KEGG pathway analysis highlighting strong enrichment for postsynaptic dysfunction, related to glutamatergic receptor signalling. We have validated some of these changes by western blot and at a single synapse level using array tomography imaging. In summary, we have generated the first unbiased map of the human ALS synaptic proteome, revealing novel insight into this key compartment in ALS pathophysiology and highlighting the influence of cognitive decline and C9ORF72-RE on synaptic composition.
36309735	81	88	C9ORF72	Gene	203228
36309735	113	118	human	Species	9606
36309735	119	122	ALS	Disease	MESH:D000690
36309735	160	180	synaptic dysfunction	Disease	MESH:C536122
36309735	228	257	Amyotrophic Lateral Sclerosis	Disease	MESH:D000690
36309735	259	262	ALS	Disease	MESH:D000690
36309735	339	342	ALS	Disease	MESH:D000690
36309735	484	487	ALS	Disease	MESH:D000690
36309735	555	560	human	Species	9606
36309735	588	591	ALS	Disease	MESH:D000690
36309735	612	615	ALS	Disease	MESH:D000690
36309735	686	689	ALS	Disease	MESH:D000690
36309735	729	736	C9ORF72	Gene	203228
36309735	770	777	C9ORF72	Gene	203228
36309735	1110	1113	ALS	Disease	MESH:D000690
36309735	1166	1172	TDP-43	Gene	23435
36309735	1174	1177	FUS	Gene	2521
36309735	1179	1183	SOD1	Gene	6647
36309735	1188	1195	C9ORF72	Gene	203228
36309735	1265	1268	ALS	Disease	MESH:D000690
36309735	1406	1409	ALS	Disease	MESH:D000690
36309735	1481	1501	cognitively impaired	Disease	MESH:D003072
36309735	1502	1505	ALS	Disease	MESH:D000690
36309735	1544	1551	C9ORF72	Gene	203228
36309735	1602	1609	C9ORF72	Gene	203228
36309735	1686	1710	postsynaptic dysfunction	Disease	MESH:D020294
36309735	1936	1941	human	Species	9606
36309735	1942	1945	ALS	Disease	MESH:D000690
36309735	2018	2021	ALS	Disease	MESH:D000690
36309735	2072	2089	cognitive decline	Disease	MESH:D003072
36309735	2094	2101	C9ORF72	Gene	203228
36309735	Association	MESH:D020294	203228
36309735	Association	MESH:D000690	6647
36309735	Association	MESH:D000690	23435
36309735	Association	MESH:D003072	203228
36309735	Association	MESH:D000690	203228
36309735	Association	MESH:D000690	2521

